Touchlight is a biotechnology company specialising in the manufacture of high-purity, cell-free DNA for genetic medicine. Its proprietary dbDNA™ enzymatic DNA technology provides scalable alternatives to traditional plasmid DNA, supporting applications including mRNA production, AAV and lentiviral vectors, gene editing, DNA vaccines and non-viral gene therapy. The company offers custom manufacturing from discovery and research scales through to GMP-grade production, alongside catalogue products for specific therapeutic and research uses. Touchlight serves developers of advanced therapies by helping accelerate DNA supply, improve purity and scalability, and support the progression of genetic medicines into clinical development.
